谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

First-in-human Phase I/II Study of CYT-0851, a First-in-class Inhibitor of RAD51-mediated Homologous Recombination in Patients with Advanced Solid and Hematologic Cancers.

Ryan C. Lynch,Johanna C. Bendell,Ranjana H. Advani,Gerald Steven Falchook,Pamela N. Munster,Manish R. Patel,Martin Gutierrez,Monika Leigh Burness,Neil Palmisiano,Mehdi Hamadani,William D. Bradley, Thomas J. O'Shea,Susan Doleman,Markus Frederic Renschler,Judson M. Englert,Timothy A. Yap

JOURNAL OF CLINICAL ONCOLOGY（2021）

引用 5|浏览44
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要